Calprotectin and Gut Disease Study

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

December 1, 2027

Conditions

Congenital Heart Disease

All Listed Sponsors

collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

Birmingham Children's Hospital

OTHER

collaborator

Alder Hey Children's NHS Foundation Trust

OTHER

lead

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

NCT07112794 - Calprotectin and Gut Disease Study | Biotech Hunter | Biotech Hunter